Last updated on February 2020

Haplo SCT vs Haplo-cord SCT for Patients With Hematological Disorders

Brief description of study

Patients who have hematological disorders and will undergo haplo-identical donor stem cell transplantation (haplo SCT) are candidates of this trial. Participants will randomized into two arms: Arm A will undergo a typical haplo SCT, while Arm B will receive an co-infusion of an unrelated cord blood unit (haplo-cord SCT) in addition to Arm A. Overall survival, progression-free survival, nonrelapse mortality and cumulative incidence of relapse will be recorded and endpoints.

Clinical Study Identifier: NCT03719534

Find a site near you

Start Over